Type of chemotherapy has substantial effects on the immune system in ovarian cancer-Reference-Cited by-同舟云学术

Type of chemotherapy has substantial effects on the immune system in ovarian cancer

Published:2021-06 Issue:6 Volume:14 Page:101076
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Vankerckhoven Ann^ORCID,Baert Thaïs,Riva Matteo^ORCID,De Bruyn Christine^ORCID,Thirion Gitte,Vandenbrande Katja,Ceusters Jolien,Vergote Ignace,Coosemans An^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Tumor mutational burden and response rate to PD-1 inhibition;Yarchoan;N. Engl. J. Med.,2017

2. Antigen-specific active immunotherapy for ovarian cancer;Paijens;Cochrane Database Syst. Rev.,2018

3. Trials in progress: iMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV o;Moore;Int. J. Gynecol. Cancer,2019

4. Immunological aspects of cancer chemotherapy;Zitvogel;Nat. Rev. Immunol.,2008

5. Immunological effects of conventional chemotherapy and targeted anticancer agents;Galluzzi;Cancer Cell,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropathy As an Adverse Effect of Chemotherapy Diminished After Administration of Dietary Supplement with Iron Citrate – Case Study;Futurity Medicine;2024-07-02

2. TIM3 Checkpoint Inhibition Fails to Prolong Survival in Ovarian Cancer-Bearing Mice;Cancers;2024-03-14

3. The antagonist of β-adrenergic receptor propranolol inhibits T cell lymphoma growth and enhances antitumor efficacy of cisplatin in vivo: A role of modulated apoptosis, glucose metabolism, pH regulation, and antitumor immune response;International Immunopharmacology;2023-11

4. Preclinical studies performed in appropriate models could help identify optimal timing of combined chemotherapy and immunotherapy;Frontiers in Immunology;2023-09-07

5. Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer;Science Translational Medicine;2023-06-07